Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 3
1991 1
1995 1
1996 4
1997 1
1998 2
1999 3
2000 1
2002 2
2005 4
2006 4
2007 4
2008 1
2009 4
2010 5
2012 4
2013 6
2014 3
2015 2
2016 1
2017 2
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
EphB4/EphrinB2 therapeutics in Rhabdomyosarcoma.
Randolph ME, Cleary MM, Bajwa Z, Svalina MN, Young MC, Mansoor A, Kaur P, Bult CJ, Goros MW, Michalek JE, Xiang S, Keck J, Krasnoperov V, Gill P, Keller C. Randolph ME, et al. Among authors: krasnoperov v. PLoS One. 2017 Aug 17;12(8):e0183161. doi: 10.1371/journal.pone.0183161. eCollection 2017. PLoS One. 2017. PMID: 28817624 Free PMC article.
EphB4 as a therapeutic target in mesothelioma.
Liu R, Ferguson BD, Zhou Y, Naga K, Salgia R, Gill PS, Krasnoperov V. Liu R, et al. Among authors: krasnoperov v. BMC Cancer. 2013 May 30;13:269. doi: 10.1186/1471-2407-13-269. BMC Cancer. 2013. PMID: 23721559 Free PMC article.
Axl-targeted cancer imaging with humanized antibody h173.
Li D, Liu S, Liu R, Park R, Yu H, Krasnoperov V, Gill PS, Li Z, Shan H, Conti PS. Li D, et al. Among authors: krasnoperov v. Mol Imaging Biol. 2014 Aug;16(4):511-8. doi: 10.1007/s11307-013-0714-z. Mol Imaging Biol. 2014. PMID: 24424460 Free PMC article.
Structure and evolution of neurexophilin.
Petrenko AG, Ullrich B, Missler M, Krasnoperov V, Rosahl TW, Südhof TC. Petrenko AG, et al. Among authors: krasnoperov v. J Neurosci. 1996 Jul 15;16(14):4360-9. doi: 10.1523/JNEUROSCI.16-14-04360.1996. J Neurosci. 1996. PMID: 8699246 Free PMC article.
EphB4-targeted imaging with antibody h131, h131-F(ab')2 and h131-Fab.
Li D, Liu S, Liu R, Zhou Y, Park R, Naga K, Krasnoperov V, Gill PS, Li Z, Shan H, Conti PS. Li D, et al. Among authors: krasnoperov v. Mol Pharm. 2013 Dec 2;10(12):4527-33. doi: 10.1021/mp400354y. Epub 2013 Nov 7. Mol Pharm. 2013. PMID: 24147882 Free PMC article.
EPHB4 is a therapeutic target in AML and promotes leukemia cell survival via AKT.
Merchant AA, Jorapur A, McManus A, Liu R, Krasnoperov V, Chaudhry P, Singh M, Harton L, Agajanian M, Kim M, Triche TJ Jr, Druker BJ, Tyner JW, Gill PS. Merchant AA, et al. Among authors: krasnoperov v. Blood Adv. 2017 Aug 28;1(20):1635-1644. doi: 10.1182/bloodadvances.2017005694. eCollection 2017 Sep 12. Blood Adv. 2017. PMID: 29296810 Free PMC article.
Targeting the EphB4 receptor for cancer diagnosis and therapy monitoring.
Li D, Liu S, Liu R, Park R, Hughes L, Krasnoperov V, Gill PS, Li Z, Shan H, Conti PS. Li D, et al. Among authors: krasnoperov v. Mol Pharm. 2013 Jan 7;10(1):329-36. doi: 10.1021/mp300461b. Epub 2012 Dec 18. Mol Pharm. 2013. PMID: 23211050 Free PMC article.
56 results